Rivastigmine in Mild Alzheimer's Disease, FMRI Study
NCT00627848
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer' Disease
Interventions
DRUG:
rivastigmine
Sponsor
Kuopio University Hospital